Tokyo Tape
Sign in
← AFC-HD AMS Life Science

Quarterly report · Q1

2927.TEDINET S100PYEL
Period2022-09-01 → 2022-11-30
Filed2023-01-13
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
MetricValuePeriodScopeSource row
Revenue¥5.7bn2022-09-01 → 2022-11-30Cons.Net sales
Revenue¥23.0bn2021-09-01 → 2022-08-31Cons.Net sales (5-year summary)
Revenue¥5.5bn2021-09-01 → 2021-11-30Cons.Net sales
Operating income¥222m2022-09-01 → 2022-11-30Cons.Operating income
Operating income¥167m2021-09-01 → 2021-11-30Cons.Operating income
Ordinary income¥236m2022-09-01 → 2022-11-30Cons.Ordinary income
Ordinary income¥1.3bn2021-09-01 → 2022-08-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥317m2021-09-01 → 2021-11-30Cons.Ordinary income
Profit before tax¥239m2022-09-01 → 2022-11-30Cons.Income before income taxes
Profit before tax¥301m2021-09-01 → 2021-11-30Cons.Income before income taxes
Net income (owners)¥161m2022-09-01 → 2022-11-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥735m2021-09-01 → 2022-08-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥156m2021-09-01 → 2021-11-30Cons.Profit loss attributable to owners of parent
Net income¥160m2022-09-01 → 2022-11-30Cons.Profit loss
Net income¥156m2021-09-01 → 2021-11-30Cons.Profit loss
Total assets¥38.1bnat 2022-11-30Cons.Assets
Total assets¥37.3bnat 2022-08-31Cons.Assets
Total assets¥36.1bnat 2021-11-30Cons.Total assets (5-year summary)
Total liabilities¥25.8bnat 2022-11-30Cons.Liabilities
Total liabilities¥24.9bnat 2022-08-31Cons.Liabilities
Net assets / equity¥12.4bnat 2022-11-30Cons.Net assets
Net assets / equity¥12.4bnat 2022-08-31Cons.Net assets
Net assets / equity¥12.6bnat 2021-11-30Cons.Net assets (5-year summary)
Cash and deposits¥10.5bnat 2022-11-30Cons.Cash and deposits
Cash and deposits¥10.4bnat 2022-08-31Cons.Cash and deposits
EPS (basic)¥11.442022-09-01 → 2022-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥52.332021-09-01 → 2022-08-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥11.042021-09-01 → 2021-11-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥11.432022-09-01 → 2022-11-30Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥52.082021-09-01 → 2022-08-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥10.972021-09-01 → 2021-11-30Cons.Diluted earnings per share (5-year summary)
Equity ratio32.5%at 2022-11-30Cons.Equity to asset ratio (5-year summary)
Equity ratio33.2%at 2022-08-31Cons.Equity to asset ratio (5-year summary)
Equity ratio32.4%at 2021-11-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 36
SegmentItemPeriodValue
Otherother segmentsrevenue2022-09-01 → 2022-11-30¥27m
Otherother segmentsrevenue external2022-09-01 → 2022-11-30¥27m
Otherother segmentssegment profit2022-09-01 → 2022-11-30−¥4m
jpcrp040300-q1r_E01064-000Department Store Businessreportable segmentrevenue2022-09-01 → 2022-11-30¥1.2bn
jpcrp040300-q1r_E01064-000Department Store Businessreportable segmentrevenue external2022-09-01 → 2022-11-30¥1.2bn
jpcrp040300-q1r_E01064-000Department Store Businessreportable segmentsegment profit2022-09-01 → 2022-11-30−¥86m
jpcrp040300-q1r_E01064-000Food Service Businessreportable segmentrevenue2022-09-01 → 2022-11-30¥376m
jpcrp040300-q1r_E01064-000Food Service Businessreportable segmentrevenue external2022-09-01 → 2022-11-30¥376m
jpcrp040300-q1r_E01064-000Food Service Businessreportable segmentsegment profit2022-09-01 → 2022-11-30−¥82m
jpcrp040300-q1r_E01064-000Health Carereportable segmentrevenue2022-09-01 → 2022-11-30¥3.6bn
jpcrp040300-q1r_E01064-000Health Carereportable segmentrevenue external2022-09-01 → 2022-11-30¥3.6bn
jpcrp040300-q1r_E01064-000Health Carereportable segmentsegment profit2022-09-01 → 2022-11-30¥470m
jpcrp040300-q1r_E01064-000Medical Productsreportable segmentrevenue2022-09-01 → 2022-11-30¥525m
jpcrp040300-q1r_E01064-000Medical Productsreportable segmentrevenue external2022-09-01 → 2022-11-30¥525m
jpcrp040300-q1r_E01064-000Medical Productsreportable segmentsegment profit2022-09-01 → 2022-11-30¥47m
Total Of Reportable Segments And Otherssegment totalrevenue2022-09-01 → 2022-11-30¥5.7bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-09-01 → 2022-11-30¥5.7bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-09-01 → 2022-11-30¥346m
Otherother segmentsrevenue2021-09-01 → 2021-11-30¥7m
Otherother segmentsrevenue external2021-09-01 → 2021-11-30¥7m
Otherother segmentssegment profit2021-09-01 → 2021-11-30¥1m
jpcrp040300-q1r_E01064-000Department Store Businessreportable segmentrevenue2021-09-01 → 2021-11-30¥954m
jpcrp040300-q1r_E01064-000Department Store Businessreportable segmentrevenue external2021-09-01 → 2021-11-30¥954m
jpcrp040300-q1r_E01064-000Department Store Businessreportable segmentsegment profit2021-09-01 → 2021-11-30−¥118m
jpcrp040300-q1r_E01064-000Food Service Businessreportable segmentrevenue2021-09-01 → 2021-11-30¥124m
jpcrp040300-q1r_E01064-000Food Service Businessreportable segmentrevenue external2021-09-01 → 2021-11-30¥124m
jpcrp040300-q1r_E01064-000Food Service Businessreportable segmentsegment profit2021-09-01 → 2021-11-30−¥140m
jpcrp040300-q1r_E01064-000Health Carereportable segmentrevenue2021-09-01 → 2021-11-30¥4.0bn
jpcrp040300-q1r_E01064-000Health Carereportable segmentrevenue external2021-09-01 → 2021-11-30¥4.0bn
jpcrp040300-q1r_E01064-000Health Carereportable segmentsegment profit2021-09-01 → 2021-11-30¥551m
jpcrp040300-q1r_E01064-000Medical Productsreportable segmentrevenue2021-09-01 → 2021-11-30¥420m
jpcrp040300-q1r_E01064-000Medical Productsreportable segmentrevenue external2021-09-01 → 2021-11-30¥420m
jpcrp040300-q1r_E01064-000Medical Productsreportable segmentsegment profit2021-09-01 → 2021-11-30¥35m
Total Of Reportable Segments And Otherssegment totalrevenue2021-09-01 → 2021-11-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2021-09-01 → 2021-11-30¥5.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2021-09-01 → 2021-11-30¥329m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 366
ItemContextValueUnit
Provision for bonusesPrior1YearInstant152512000JPY
Provision for bonusesCurrentQuarterInstant177731000JPY
Contract liabilitiesPrior1YearInstant1331472000JPY
Contract liabilitiesCurrentQuarterInstant1348222000JPY
Other clPrior1YearInstant1146322000JPY
Other clCurrentQuarterInstant1196788000JPY
Current liabilitiesPrior1YearInstant13218748000JPY
Current liabilitiesCurrentQuarterInstant14105848000JPY
Long term loans payablePrior1YearInstant10136122000JPY
Long term loans payableCurrentQuarterInstant10087848000JPY
Provision for directors retirement benefitsPrior1YearInstant230435000JPY
Provision for directors retirement benefitsCurrentQuarterInstant239253000JPY
Net defined benefit liabilityPrior1YearInstant770959000JPY
Net defined benefit liabilityCurrentQuarterInstant775702000JPY
Other nclPrior1YearInstant547245000JPY
Other nclCurrentQuarterInstant541596000JPY
Noncurrent liabilitiesPrior1YearInstant11684762000JPY
Noncurrent liabilitiesCurrentQuarterInstant11644400000JPY
LiabilitiesPrior1YearInstant24903511000JPY
LiabilitiesCurrentQuarterInstant25750249000JPY
Capital stockPrior1YearInstant2131839000JPY
Capital stockCurrentQuarterInstant2131839000JPY
Capital surplusPrior1YearInstant2640231000JPY
Capital surplusCurrentQuarterInstant2632783000JPY
Retained earningsPrior1YearInstant7880483000JPY
Retained earningsCurrentQuarterInstant7830590000JPY
Treasury stockPrior1YearInstant-305391000JPY
Treasury stockCurrentQuarterInstant-274643000JPY
Shareholders equityPrior1YearInstant12347163000JPY
Shareholders equityCurrentQuarterInstant12320570000JPY
Valuation difference on available for sale securitiesPrior1YearInstant-808000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant-10274000JPY
Foreign currency translation adjustmentPrior1YearInstant25907000JPY
Foreign currency translation adjustmentCurrentQuarterInstant22251000JPY
Remeasurements of defined benefit plansPrior1YearInstant42259000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant41110000JPY
Valuation and translation adjustmentsPrior1YearInstant67358000JPY
Valuation and translation adjustmentsCurrentQuarterInstant53087000JPY
Subscription rights to sharesPrior1YearInstant24568000JPY
Subscription rights to sharesCurrentQuarterInstant996000JPY
Non controlling interestsPrior1YearInstant6058000JPY
Non controlling interestsCurrentQuarterInstant5458000JPY
Net assetsPrior1YearInstant12445149000JPY
Net assetsCurrentQuarterInstant12380112000JPY
Liabilities and net assetsPrior1YearInstant37348660000JPY
Liabilities and net assetsCurrentQuarterInstant38130361000JPY
Net salesPrior1YTDDuration5461423000JPY
Net salesCurrentYTDDuration5686422000JPY
Cost of salesPrior1YTDDuration3401764000JPY
Cost of salesCurrentYTDDuration3464457000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2022-08-31pass
balance sheet identityconsolidated 2022-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-08-31pass
statement vs summary · net assetsconsolidated 2022-11-30pass
statement vs summary · net income attributable to parentconsolidated 2021-09-01/2021-11-30pass
statement vs summary · net income attributable to parentconsolidated 2022-09-01/2022-11-30pass
statement vs summary · revenueconsolidated 2021-09-01/2021-11-30pass
statement vs summary · revenueconsolidated 2022-09-01/2022-11-30pass
statement vs summary · total assetsconsolidated 2022-08-31pass
statement vs summary · total assetsconsolidated 2022-11-30pass